DCF Advisers’s Eli Lilly LLY Stock Holding History

DCF Advisers’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.63M	Hold	8,300	–	–	2.04%	11
2025 Q4	$8.92M	Hold	8,300	–	–	2.39%	7
2025 Q3	$6.33M	Buy	8,300 +1,675	+25%	+$1.25M	2.03%	13
2025 Q2	$5.16M	Buy	6,625 +375	+6%	+$291K	2.39%	11
2025 Q1	$5.16M	Sell	6,250 -750	-11%	-$624K	2.47%	10
2024 Q4	$5.4M	Hold	7,000	–	–	2.61%	11
2024 Q3	$6.2M	Hold	7,000	–	–	2.48%	9
2024 Q2	$6.34M	Hold	7,000	–	–	3.26%	6
2024 Q1	$5.45M	Hold	7,000	–	–	2.68%	10
2023 Q4	$4.08M	Sell	7,000 -500	-7%	-$292K	2.21%	15
2023 Q3	$4.03M	Hold	7,500	–	–	2.19%	12
2023 Q2	$3.52M	Sell	7,500 -750	-9%	-$315K	1.86%	16
2023 Q1	$2.83M	Hold	8,250	–	–	1.73%	17
2022 Q4	$3.02M	Hold	8,250	–	–	2.04%	16
2022 Q3	$2.67M	Hold	8,250	–	–	1.72%	20
2022 Q2	$2.67M	Sell	8,250 -2,100	-20%	-$630K	1.59%	20
2022 Q1	$2.96M	Sell	10,350 -900	-8%	-$232K	1.3%	22
2021 Q4	$3.11M	Hold	11,250	–	–	1.26%	22
2021 Q3	$2.6M	Hold	11,250	–	–	1.15%	26
2021 Q2	$2.58M	Hold	11,250	–	–	0.91%	29
2021 Q1	$2.1M	Buy	11,250 +5,250	+88%	+$1.03M	0.91%	30
2020 Q4	$1.01M	Buy	+6,000	New	+$896K	0.42%	46

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

DCF Advisers's LLY Position: Q1 2026 in Review

DCF Advisers held its Eli Lilly (LLY) position steady in Q1 2026 at 8,300 shares worth $7.63M. The position accounts for 2.04% of the portfolio, ranked #11.

DCF Advisers first reported a position in LLY in Q4 2020 and has held it in 22 quarters since. The position peaked at $8.92M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

DCF Advisers held 8,300 shares of Eli Lilly worth $7.63M as of Q1 2026.
DCF Advisers left its Eli Lilly share count unchanged in Q1 2026.
Eli Lilly made up 2.04% of DCF Advisers's portfolio in Q1 2026, its #11 holding.
DCF Advisers first reported a position in Eli Lilly in Q4 2020 and has held it in 22 quarters since.
DCF Advisers's Eli Lilly position peaked at $8.92M in Q4 2025.
4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on DCF Advisers's 13F filing for Q1 2026, filed 11 May 2026.